
Ionctura Commences Randomized Phase I/II Study In Non-Small Cell Lung Cancer
(MENAFN- PR Newswire) First patient dosed in study investigating roginolisib + dostarlimab +/- docetaxel in patients with NSCLC who have progressed on prior immunotherapy/chemo Study will evaluate safety of the combination and explore whether …